Literature DB >> 2856106

Surgical therapy in lung cancer with single brain metastasis.

M Torre1, B Barbieri, E Bera, S Locicero, F Pieri Nerli, P A Belloni.   

Abstract

From January 1975 to April 1987, 27 patients underwent surgical resection of non oat cell lung cancer and a single brain metastasis. There were 25 men and 2 women ranging in age from 37 to 70 years. In 21 cases the brain metastasis was synchronous while in 6 cases the onset was metachronous. In 17 cases, the site of the brain metastasis was supratentorial and in 10 cases it was located in the posterior fossa. The chest X-ray confirmed the primary lung tumour in 24 cases. In 3 cases, only bronchoscopy and cytology revealed the primary focus of the tumour. The lung cancer was located in the upper lobe in 25 patients. Upper lobectomy was performed in 23 patients, pneumonectomy in 3, and lower lobectomy in 1. There were no operative deaths. The cell type was adenocarcinoma in 19 cases, squamous cell carcinoma in 4 patients and large cell carcinoma in 4. Only the tumour and nodes were used for staging at thoracotomy. The classification was: 12 patients in stage I, 2 in stage II, and 13 in stage III. At conclusion of the study the longest survival was 68 months after thoracotomy. There was no significant difference in the duration of survival in patients over or under 50 years old. Better results were obtained in patients without node metastases at thoracotomy (median survival of 30 months and an overall 5-year survival of 35%), and in patients with supratentorial metastases (median survival of 22 months and an overall 5-year survival of 23.4%). Our experience confirms that combined surgery prolongs survival and improves the quality of life.

Entities:  

Mesh:

Year:  1988        PMID: 2856106     DOI: 10.1016/1010-7940(88)90008-5

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy.

Authors:  C Y Hsiung; S W Leung; C J Wang; S K Lo; H C Chen; L M Sun; F M Fang
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

Review 2.  Surgical approach in the oligometastatic patient.

Authors:  Duilio Divisi; Mirko Barone; Gino Zaccagna; Francesca Gabriele; Roberto Crisci
Journal:  Ann Transl Med       Date:  2018-03

3.  Surgery in bronchial carcinoma with metastasis.

Authors:  J Hasse
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Surgical Management of Non-small Cell Lung Cancer with Solitary Hematogenous Metastases.

Authors:  Grigorios Karagkiouzis; Eleftherios Spartalis; Demetrios Moris; Demetrios Patsouras; Athanasios Athanasiou; Ioannis Karathanasis; Alexios Verveniotis; Froso Konstantinou; Ilias A Kouerinis; Konstantinos Potaris; Dimitrios Dimitroulis; Periklis Tomos
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

5.  Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis.

Authors:  Takashi Kanou; Jiro Okami; Toshiteru Tokunaga; Ayako Fujiwara; Daisuke Ishida; Hidenori Kuno; Masahiko Higashiyama
Journal:  Surg Today       Date:  2014-04-20       Impact factor: 2.549

Review 6.  Oligometastatic non-small-cell lung cancer: current treatment strategies.

Authors:  Patrick J Richard; Ramesh Rengan
Journal:  Lung Cancer (Auckl)       Date:  2016-11-04

7.  Results of surgical resection in lung cancer with synchronous brain metastasis.

Authors:  Volkan Baysungur; Çagatay Tezel; Hakan Kıral; Bora Gürer; Serda Metin Kanbur; Levent Alpay; Talha Doğruyol; Deniz Gürer; Hakan Yılmaz
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-04-24       Impact factor: 0.332

8.  Oligometastatic non-small cell lung cancer: a significant entity outside of specialized cancer centers?

Authors:  Carsten Nieder; Terje Tollåli; Anne Reigstad; Adam Pawinski; Ellinor Haukland; Astrid Dalhaug
Journal:  Med Princ Pract       Date:  2014-09-03       Impact factor: 1.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.